Sodium reduction trial by urinary Na/K self-monitoring

Not Applicable

• Conditions: /A

• Registration Number: JPRN-UMIN000030934
• Lead Sponsor: Kyoto University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-01
• Study Completion: 2018-12-15
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

Not provided

Exclusion Criteria

Pregnancy Hemodialysis Pacemaker implantation Insulin therapy Renal functional decline [renal failure, chronic kidney disease, nephrosis syndrome] Albuminuria [>++ by urine test paper, or urinary albumin >100 mg/dl] Hepatic diseases [cirrhosis, hepatic failure] Heart diseases [ischemic diseases, heart failure, bradycardia, arrhythmia] Cancer Chronic inflammatory bowel disease Chronic diarrhea, or history of dehydration Orthostatic dysregulation, or syncope Hypotension [systolic blood pressure <100 mmHg] Low body weigh [body mass index <16.5 kg/m2]

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in spot-urine Na/K at one and two month after starting the intervention.

Secondary Outcome Measures

Name	Time	Method
Changes in sodium intake measured using 24-hour urine sample, and blood pressure and body weight measured at home.